December, 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Sajja Venkatesh on the Results of CREST-2 Trial
Nov 30, 2025, 09:42

Sajja Venkatesh on the Results of CREST-2 Trial

Sajja Venkatesh, Interventional Neurologist, FNB-NeuroVascular Intervention at Apollo Hospitals, shared on LinkedIn:

”CREST-2 Trial: Carotid artery stenting (CAS) vs Carotid Endarterectomy (CEA) for asymptomatic high-grade carotid stenosis (≥70%) who have not had recent stroke symptoms,

  • Addition of CAS resulted in a reduced risk of a composite of perioperative stroke, death, or ipsilateral stroke within a 4 year timeframe, surpassing the outcomes achieved through intensive medical management alone.
  • Conversely, CEA did not demonstrate a statistically significant advantage.

Primary Outcome:

– Stenting Trial: The 4-year incidence of stroke or death was significantly lower in the stenting group (2.8%) compared to the medical-therapy group (6.0%), with an absolute risk reduction of 3.2 percentage points (P=0.02).

– Endarterectomy Trial: No significant difference was observed between the endarterectomy group (3.7%) and the medical-therapy group (5.3%) (P=0.24).”

Read the full article here.

Article: Medical Management and Revascularization for Asymptomatic Carotid Stenosis

Authors: CREST-2 Investigators

Sajja Venkatesh on the Results of CREST-2 Trial

Stay updated on all scientific advances with Hemostasis Today.